These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 11511570)

  • 1. Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives.
    Halter F; Tarnawski AS; Schmassmann A; Peskar BM
    Gut; 2001 Sep; 49(3):443-53. PubMed ID: 11511570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cyclooxygenase isoforms in gastric mucosal defence.
    Peskar BM
    J Physiol Paris; 2001; 95(1-6):3-9. PubMed ID: 11595412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cyclooxygenase-2 in gastric mucosal defense.
    Peskar BM; Maricic N; Gretzera B; Schuligoi R; Schmassmann A
    Life Sci; 2001 Nov; 69(25-26):2993-3003. PubMed ID: 11758826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor.
    Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Schuppan D; Drozdowicz D; Ptak A; Pawlik M; Nakamura T; Hahn EG
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):751-73. PubMed ID: 11192947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing.
    Jones MK; Wang H; Peskar BM; Levin E; Itani RM; Sarfeh IJ; Tarnawski AS
    Nat Med; 1999 Dec; 5(12):1418-23. PubMed ID: 10581086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of local application of growth factors on gastric ulcer healing and mucosal expression of cyclooxygenase-1 and -2.
    Brzozowski T; Konturek PC; Konturek SJ; Schuppan D; Drozdowicz D; KwiecieĊ„ S; Majka J; Nakamura T; Hahn E
    Digestion; 2001; 64(1):15-29. PubMed ID: 11549833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention.
    Ballinger A; Smith G
    Expert Opin Pharmacother; 2001 Jan; 2(1):31-40. PubMed ID: 11336566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Are COX-2 inhibitors truly able to prevent NSAIDs-associated ulcer?].
    Nishida T; Tsujii M; Tsuji S
    Nihon Rinsho; 2004 Mar; 62(3):561-5. PubMed ID: 15038104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
    Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F
    Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs.
    Cryer B; Feldman M
    Am J Med; 1998 May; 104(5):413-21. PubMed ID: 9626023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
    Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
    J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal sparing anti-inflammatory drugs--effects on ulcerogenic and healing responses.
    Takeuchi K; Tanaka A; Suzuki K; Mizoguchi H
    Curr Pharm Des; 2001 Jan; 7(1):49-69. PubMed ID: 11172701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Helicobacter pylori on delay in ulcer healing induced by aspirin in rats.
    Konturek PC; Brzozowski T; KwiecieĊ„ S; Drozdowicz D; Harsch IA; Meixner H; Stachura J; Hahn EG; Konturek SJ
    Eur J Pharmacol; 2002 Sep; 451(2):191-202. PubMed ID: 12231391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of ulcer healing and effects of nonsteroidal anti-inflammatory drugs.
    Schmassmann A
    Am J Med; 1998 Mar; 104(3A):43S-51S; discussion 79S-80S. PubMed ID: 9572320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing.
    Colucci R; Antonioli L; Bernardini N; Ippolito C; Segnani C; Awwad O; Tuccori M; Blandizzi C; Scarpignato C; Fornai M
    J Pharmacol Exp Ther; 2012 Jul; 342(1):140-9. PubMed ID: 22495067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic.
    Warner TD; Mitchell JA
    FASEB J; 2004 May; 18(7):790-804. PubMed ID: 15117884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of H. pylori infection and NSAIDs in cyclooxygenase-2 mRNA expression in gastric antral, corpus mucosa, and gastric ulcer.
    Wu CY; Wu MS; Chen CJ; Li MC; Lin JT; Chen GH
    J Clin Gastroenterol; 2005 Jan; 39(1):50-5. PubMed ID: 15599211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.